Compare NMAD & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMAD | PLRX |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 69.7M |
| IPO Year | 2020 | 2020 |
| Metric | NMAD | PLRX |
|---|---|---|
| Price | $4.32 | $1.01 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $2.67 |
| AVG Volume (30 Days) | 171.5K | ★ 353.8K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.75 | ★ 29.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $200,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.12 | $0.97 |
| 52 Week High | $6.28 | $1.95 |
| Indicator | NMAD | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 35.88 |
| Support Level | $3.14 | N/A |
| Resistance Level | $4.55 | $1.37 |
| Average True Range (ATR) | 0.27 | 0.04 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 89.78 | 22.22 |
Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.